These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 19638042)
1. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study. Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study. Nakagawa R; Shigehara K; Aoyama S; Urata S; Ofude M; Miyagi T; Nakashima T; Izumi K; Mizokami A J Infect Chemother; 2019 May; 25(5):337-340. PubMed ID: 30718193 [TBL] [Abstract][Full Text] [Related]
6. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185 [TBL] [Abstract][Full Text] [Related]
7. Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? Tuncel A; Aslan Y; Sezgin T; Aydin O; Tekdogan U; Atan A Urology; 2008 Jun; 71(6):1024-7; discussion 1027-8. PubMed ID: 18400273 [TBL] [Abstract][Full Text] [Related]
8. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Lindstedt S; Lindström U; Ljunggren E; Wullt B; Grabe M Eur Urol; 2006 Oct; 50(4):832-7. PubMed ID: 16750292 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy]. Yang L; Hu J; Wei H; Wang L; Zhong H Zhonghua Wai Ke Za Zhi; 2001 Dec; 39(12):940-2. PubMed ID: 16201177 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. Shigemura K; Tanaka K; Yasuda M; Ishihara S; Muratani T; Deguchi T; Matsumoto T; Kamidono S; Nakano Y; Arakawa S; Fujisawa M World J Urol; 2005 Nov; 23(5):356-60. PubMed ID: 16254727 [TBL] [Abstract][Full Text] [Related]
11. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043 [TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. Cam K; Kayikci A; Akman Y; Erol A Int J Urol; 2008 Oct; 15(11):997-1001. PubMed ID: 18721198 [TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609 [TBL] [Abstract][Full Text] [Related]
15. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications. Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324 [TBL] [Abstract][Full Text] [Related]
16. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study. Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. Adibi M; Pearle MS; Lotan Y BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356 [TBL] [Abstract][Full Text] [Related]
18. [Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination]. Wang H; Zhou X; Chen S; Zhu C; Yu X Zhonghua Nan Ke Xue; 2004 Jul; 10(7):496-8, 502. PubMed ID: 15354517 [TBL] [Abstract][Full Text] [Related]
19. [Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomised study]. Briffaux R; Merlet B; Normand G; Coloby P; Leremboure H; Bruyère F; Pires C; Ouaki F; Doré B; Irani J Prog Urol; 2009 Jan; 19(1):39-46. PubMed ID: 19135641 [TBL] [Abstract][Full Text] [Related]
20. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Young JL; Liss MA; Szabo RJ Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]